Document
PAZEO, 206276, Letter (Orange Book Jul. 13, 2020)
Cite Document
PAZEO, 206276, Letter (Orange Book Jul. 13, 2020)
+ More Snippets
Document
PATADAY ONCE DAILY RELIEF, 206276, Review (Orange Book Jul. 13, 2020)
Cite Document
PATADAY ONCE DAILY RELIEF, 206276, Review (Orange Book Jul. 13, 2020)
+ More Snippets
Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. KDYUP4KYRXEAPX4 (U.S. Pat. App. Aug. 6, 2020)
Cite Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. KDYUP4KYRXEAPX4 (U.S. Pat. App. Aug. 6, 2020)
+ More Snippets
Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. JX52NBVGRXEAPX1 (U.S. Pat. App. Jun. 20, 2019)
Cite Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. JX52NBVGRXEAPX1 (U.S. Pat. App. Jun. 20, 2019)
+ More Snippets
Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. JNLR55KWRXEAPX5 (U.S. Pat. App. Oct. 23, 2018)
Cite Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. JNLR55KWRXEAPX5 (U.S. Pat. App. Oct. 23, 2018)
+ More Snippets
Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. JK8MXLP9RXEAPX0 (U.S. Pat. App. Jul. 30, 2018)
Cite Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. JK8MXLP9RXEAPX0 (U.S. Pat. App. Jul. 30, 2018)
+ More Snippets
Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. JHKMIIA8RXEAPX2 (U.S. Pat. App. May. 24, 2018)
Cite Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. JHKMIIA8RXEAPX2 (U.S. Pat. App. May. 24, 2018)
+ More Snippets
Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. JDZ2NWEHRXEAPX4 (U.S. Pat. App. Feb. 22, 2018)
Cite Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. JDZ2NWEHRXEAPX4 (U.S. Pat. App. Feb. 22, 2018)
+ More Snippets
Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. JC6H1LGARXEAPX5 (U.S. Pat. App. Jan. 8, 2018)
Cite Document
HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION, 14/304,124, No. JC6H1LGARXEAPX5 (U.S. Pat. App. Jan. 8, 2018)
+ More Snippets
Document
IPR2020-00295, No. 2003-47 Exhibit - Declaration of Erning Xia, Argentum Pharm v Alcon Research,IPR2016 00544 PTAB Jan 31, 2016 (P.T.A.B. May. 15, 2020)
Cite Document
IPR2020-00295, No. 2003-47 Exhibit - Declaration of Erning Xia, Argentum Pharm v Alcon Research,IPR2016 00544 PTAB Jan 31, 2016 (P.T.A.B. May. 15, 2020)
+ More Snippets
Document
IPR2020-00295, No. 2009-53 Exhibit - Petition, Cipla Ltd v Alcon Research, IPR2018 01021 PTAB June 5, 2018 (P.T.A.B. May. 15, 2020)
Cite Document
IPR2020-00295, No. 2009-53 Exhibit - Petition, Cipla Ltd v Alcon Research, IPR2018 01021 PTAB June 5, 2018 (P.T.A.B. May. 15, 2020)
+ More Snippets
Document
IPR2020-00295, No. 1044-62 Exhibit - Exhibit 1044 Telephone Conference Call Transcript (P.T.A.B. Jun. 5, 2020)
Cite Document
IPR2020-00295, No. 1044-62 Exhibit - Exhibit 1044 Telephone Conference Call Transcript (P.T.A.B. Jun. 5, 2020)
+ More Snippets
Document
IPR2020-00295, No. 2004-48 Exhibit - Declaration of Leonard Bielory, Argentum Pharm v Alcon Research, IPR2016 00544 PTAB Feb 2, 2016 (P.T.A.B. May. 15, 2020)
Cite Document
IPR2020-00295, No. 2004-48 Exhibit - Declaration of Leonard Bielory, Argentum Pharm v Alcon Research, IPR2016 00544 PTAB Feb 2, 2016 (P.T.A.B. May. 15, 2020)
+ More Snippets
Document
IPR2020-00295, No. 2012-56 Exhibit - Ayla Pharma LLC Statement of Information Dec 18, 2019 (P.T.A.B. May. 15, 2020)
Cite Document
IPR2020-00295, No. 2012-56 Exhibit - Ayla Pharma LLC Statement of Information Dec 18, 2019 (P.T.A.B. May. 15, 2020)
+ More Snippets
Document
IPR2020-00295, No. 2006-50 Exhibit - Day 2 Trial Transcript, Oct 3, 2017, Alcon v Watson, No 15 cv 1159 D Del (P.T.A.B. May. 15, 2020)
Cite Document
IPR2020-00295, No. 2006-50 Exhibit - Day 2 Trial Transcript, Oct 3, 2017, Alcon v Watson, No 15 cv 1159 D Del (P.T.A.B. May. 15, 2020)
+ More Snippets